de Jennison Associates DexCom DXCM Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Vender |
-1,048,097
| Cerradas | -USD 65.8 M | – | 579 |
|
|
2026
Q1 | USD 65.8 M | Vender |
1,048,097
-4,741,847
| -82% | -USD 330 M | 0.05% | 186 |
|
|
2025
Q4 | USD 384 M | Vender |
5,789,944
-4,300,430
| -43% | -USD 278 M | 0.23% | 50 |
|
|
2025
Q3 | USD 679 M | Vender |
10,090,374
-1,427,172
| -12% | -USD 113 M | 0.4% | 40 |
|
|
2025
Q2 | USD 1005 M | Comprar |
11,517,546
+994,300
| +9% | +USD 77.9 M | 0.6% | 35 |
|
|
2025
Q1 | USD 719 M | Comprar |
10,523,246
+2,879,489
| +38% | +USD 235 M | 0.5% | 41 |
|
|
2024
Q4 | USD 594 M | Comprar |
7,643,757
+710,858
| +10% | +USD 52.6 M | 0.36% | 49 |
|
|
2024
Q3 | USD 465 M | Comprar |
6,932,899
+6,544,102
| +1,683% | +USD 537 M | 0.29% | 52 |
|
|
2024
Q2 | USD 44.1 M | Comprar |
388,797
+495
| +0.1% | +USD 62.6 k | 0.03% | 228 |
|
|
2024
Q1 | USD 53.9 M | Comprar |
388,302
+10,217
| +3% | +USD 1.28 M | 0.04% | 199 |
|
|
2023
Q4 | USD 46.9 M | Vender |
378,085
-3,914,081
| -91% | -USD 400 M | 0.04% | 213 |
|
|
2023
Q3 | USD 400 M | Vender |
4,292,166
-2,990,021
| -41% | -USD 337 M | 0.34% | 47 |
|
|
2023
Q2 | USD 936 M | Comprar |
7,282,187
+17,192
| +0.2% | +USD 2.08 M | 0.77% | 33 |
|
|
2023
Q1 | USD 844 M | Vender |
7,264,995
-1,921,227
| -21% | -USD 215 M | 0.77% | 38 |
|
|
2022
Q4 | USD 1040 M | Comprar |
9,186,222
+2,242,846
| +32% | +USD 246 M | 1.05% | 28 |
|
|
2022
Q3 | USD 559 M | Vender |
6,943,376
-1,620,235
| -19% | -USD 137 M | 0.56% | 41 |
|
|
2022
Q2 | USD 638 M | Vender |
8,563,611
-1,837,521
| -18% | -USD 168 M | 0.64% | 38 |
|
|
2022
Q1 | USD 1330 M | Comprar |
10,401,132
+4,730,528
| +83% | +USD 517 M | 0.98% | 27 |
|
|
2021
Q4 | USD 761 M | Vender |
5,670,604
-504,824
| -8% | -USD 72.5 M | 0.48% | 47 |
|
|
2021
Q3 | USD 844 M | Vender |
6,175,428
-215,340
| -3% | -USD 27.2 M | 0.55% | 44 |
|
|
2021
Q2 | USD 682 M | Vender |
6,390,768
-412,768
| -6% | -USD 39.6 M | 0.45% | 47 |
|
|
2021
Q1 | USD 611 M | Vender |
6,803,536
-1,157,352
| -15% | -USD 109 M | 0.45% | 47 |
|
|
2020
Q4 | USD 736 M | Vender |
7,960,888
-2,990,572
| -27% | -USD 267 M | 0.52% | 47 |
|
|
2020
Q3 | USD 1129 M | Vender |
10,951,460
-96,364
| -0.9% | -USD 10.1 M | 0.91% | 31 |
|
|
2020
Q2 | USD 1120 M | Comprar |
11,047,824
+273,476
| +3% | +USD 24.5 M | 1.01% | 29 |
|
|
2020
Q1 | USD 725 M | Vender |
10,774,348
-3,060,684
| -22% | -USD 190 M | 0.88% | 29 |
|
|
2019
Q4 | USD 757 M | Vender |
13,835,032
-2,323,332
| -14% | -USD 110 M | 0.76% | 38 |
|
|
2019
Q3 | USD 603 M | Comprar |
16,158,364
+10,590,444
| +190% | +USD 411 M | 0.64% | 42 |
|
|
2019
Q2 | USD 209 M | Comprar |
5,567,920
+3,778,568
| +211% | +USD 119 M | 0.21% | 65 |
|
|
2019
Q1 | USD 53.3 M | Comprar |
1,789,352
+51,564
| +3% | +USD 1.81 M | 0.05% | 213 |
|
|
2018
Q4 | USD 52 M | Vender |
1,737,788
-342,752
| -16% | -USD 10.9 M | 0.06% | 199 |
|
|
2018
Q3 | USD 74.4 M | Vender |
2,080,540
-418,540
| -17% | -USD 13 M | 0.07% | 194 |
|
|
2018
Q2 | USD 59.3 M | Vender |
2,499,080
-1,410,956
| -36% | -USD 29.9 M | 0.06% | 237 |
|
|
2018
Q1 | USD 72.5 M | Vender |
3,910,036
-1,202,760
| -24% | -USD 17.8 M | 0.07% | 203 |
|
|
2017
Q4 | USD 73.4 M | Vender |
5,112,796
-1,615,164
| -24% | -USD 21 M | 0.07% | 210 |
|
|
2017
Q3 | USD 82.3 M | Vender |
6,727,960
-376,204
| -5% | -USD 6.65 M | 0.08% | 196 |
|
|
2017
Q2 | USD 130 M | Comprar |
7,104,164
+1,115,648
| +19% | +USD 20.6 M | 0.14% | 113 |
|
|
2017
Q1 | USD 127 M | Comprar |
5,988,516
+124,328
| +2% | +USD 2.43 M | 0.14% | 118 |
|
|
2016
Q4 | USD 87.5 M | Comprar |
5,864,188
+1,056,428
| +22% | +USD 18.7 M | 0.1% | 178 |
|
|
2016
Q3 | USD 105 M | Vender |
4,807,760
-2,062,536
| -30% | -USD 45.9 M | 0.11% | 151 |
|
|
2016
Q2 | USD 136 M | Comprar |
6,870,296
+629,468
| +10% | +USD 10.7 M | 0.15% | 119 |
|
|
2016
Q1 | USD 106 M | Comprar |
6,240,828
+1,550,544
| +33% | +USD 25.9 M | 0.11% | 161 |
|
|
2015
Q4 | USD 96 M | Comprar |
4,690,284
+833,836
| +22% | +USD 17.4 M | 0.09% | 178 |
|
|
2015
Q3 | USD 82.8 M | Comprar |
3,856,448
+2,492,236
| +183% | +USD 55.6 M | 0.08% | 211 |
|
|
2015
Q2 | USD 27.3 M | Comprar |
1,364,212
+1,199,904
| +730% | +USD 21.1 M | 0.03% | 425 |
|
|
2015
Q1 | USD 2.56 M | Vender |
164,308
-81,344
| -33% | -USD 1.23 M | ﹤0.01% | 579 |
|
|
2014
Q4 | USD 3.38 M | Vender |
245,652
-28,868
| -11% | -USD 353 k | ﹤0.01% | 542 |
|
|
2014
Q3 | USD 2.74 M | Vender |
274,520
-7,952
| -3% | -USD 81.3 k | ﹤0.01% | 551 |
|
|
2014
Q2 | USD 2.8 M | Comprar |
282,472
+92,352
| +49% | +USD 818 k | ﹤0.01% | 543 |
|
|
2014
Q1 | USD 1.97 M | Vender |
190,120
-176,840
| -48% | -USD 1.83 M | ﹤0.01% | 590 |
|
|
2013
Q4 | USD 3.25 M | Vender |
366,960
-56,772
| -13% | -USD 449 k | ﹤0.01% | 530 |
|
|
2013
Q3 | USD 2.99 M | Comprar |
423,732
+92,896
| +28% | +USD 589 k | ﹤0.01% | 542 |
|
|
2013
Q2 | USD 1.86 M | Comprar |
+330,836
| Nuevas | +USD 1.58 M | ﹤0.01% | 541 |
|
Otros fondos que tienen DXCM en su cartera
Posición de Jennison Associates en DXCM: resumen de T2 2026
Jennison Associates cerró por completo su posición en DexCom (DXCM) en T2 2026, liquidando una posición de 1,048,097 acciones por un valor estimado de USD 65.8 M.
Jennison Associates reportó por primera vez una posición en DXCM en T2 2013 y la mantuvo durante 52 trimestres. La posición alcanzó su máximo de USD 1330 M en T1 2022. Al cierre de T2 2026, 979 fondos que sigue Wall St. Rank mantienen una posición en DXCM.
- Jennison Associates reportó que ya no tenía una posición en DexCom al cierre de T2 2026, después de venderla por completo durante el trimestre.
- Jennison Associates vendió 1,048,097 acciones de DexCom en T2 2026, por un valor estimado de USD 65.8 M.
- Jennison Associates reportó por primera vez una posición en DexCom en T2 2013 y la mantuvo durante 52 trimestres.
- La posición de Jennison Associates en DexCom alcanzó su máximo de USD 1330 M en T1 2022.
- Al cierre de T2 2026, 979 fondos que sigue Wall St. Rank tenían DexCom en cartera.
Según el Informe 13F de Jennison Associates correspondiente a T2 2026, presentado el 3 ago 2026.